Updated logo UPDATED Back to feed
pulse TechSpot September 16, 2026

Researchers use genetically engineered immune cells to put a child's metastatic cancer into remission

Researchers use genetically engineered immune cells to put a child's metastatic cancer into remission
AI Summary

A young boy with metastatic cancer was treated with an innovative immunotherapy technique, and after 12 months, the cancer appears to be completely gone. The technique is known as chimeric antigen receptor (CAR) T-cell therapy and is designed to fight cancer cells from inside the body rather than relying on...

0 views
Read full article
Read it on Updated — Tech News. Ahead of the Curve.
Discussion
Sign in to join the discussion.
Loading comments…